Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia
Long Wang, Liang Xie, Francis Tintani, et al.
Stem Cells Translational Medicine (2016) Vol. 6, Iss. 2, pp. 394-404
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

TGF-β signaling in health, disease and therapeutics
Ziqin Deng, Tao Fan, Xiao Chu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 187
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 116
TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer
Virgínea Farias, Ana Belén Carrillo-Gálvez, Francisco Martı́n, et al.
Cytokine & Growth Factor Reviews (2018) Vol. 43, pp. 25-37
Closed Access | Times Cited: 112
Tumor‐infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
Timothy Krueger, Daniel L.J. Thorek, Alan K. Meeker, et al.
The Prostate (2018) Vol. 79, Iss. 3, pp. 320-330
Open Access | Times Cited: 77
Targeting phenotypic heterogeneity in benign prostatic hyperplasia
Douglas W. Strand, Daniel N. Costa, Franto Francis, et al.
Differentiation (2017) Vol. 96, pp. 49-61
Open Access | Times Cited: 59
Animal models of benign prostatic hyperplasia
Junjie Zhang, Mengda Zhang, Jin Tang, et al.
Prostate Cancer and Prostatic Diseases (2020) Vol. 24, Iss. 1, pp. 49-57
Closed Access | Times Cited: 39
Ras homolog family member A/Rho-associated protein kinase 1 signaling modulates lineage commitment of mesenchymal stem cells in asthmatic patients through lymphoid enhancer–binding factor 1
Ke Xia, C. Danh, Changjun Li, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 4, pp. 1560-1574.e6
Open Access | Times Cited: 38
Mesenchymal stem cells and the embryonic reawakening theory of BPH
W. Nathaniel Brennen, John T. Isaacs
Nature Reviews Urology (2018) Vol. 15, Iss. 11, pp. 703-715
Open Access | Times Cited: 38
Cellular senescence as a possible link between prostate diseases of the ageing male
G. Fiard, Vasilis Stavrinides, Emma S. Chambers, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 10, pp. 597-610
Open Access | Times Cited: 31
Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia
Youyou Li, Jiaren Li, Liang Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
<p>Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats</p>
Bahaa Al‐Trad, Alaa A. A. Aljabali, Mazhar Salim Al Zoubi, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 3145-3154
Open Access | Times Cited: 35
Exendin-4 Induces Bone Marrow Stromal Cells Migration Through Bone Marrow-Derived Macrophages Polarization via PKA-STAT3 Signaling Pathway
Ning Wang, Jianxi Gao, Min Jia, et al.
Cellular Physiology and Biochemistry (2017) Vol. 44, Iss. 5, pp. 1696-1714
Open Access | Times Cited: 30
Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats
Basma H. Marghani, Alaa Fehaid, Ahmed Ateya, et al.
Life Sciences (2021) Vol. 291, pp. 120240-120240
Closed Access | Times Cited: 22
Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats
Jin Zhou, Yongfang Lei, Jinglou Chen, et al.
International Immunopharmacology (2018) Vol. 64, pp. 162-169
Closed Access | Times Cited: 27
Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals
Zhenyu Ou, Yao He, Lin Qi, et al.
Oncotarget (2017) Vol. 8, Iss. 35, pp. 59156-59164
Open Access | Times Cited: 25
Attenuating osteoarthritis by a high efficient anti-bone resorption injectable pH-responsive bisphosphonate-conjugated nano-apatite system
Zhen Geng, Xiaogang Wang, Yuanman Yu, et al.
Chemical Engineering Journal (2020) Vol. 420, pp. 127674-127674
Closed Access | Times Cited: 23
The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways
Michael J. Birrer, Keiichi Fujiwara, Ana Oaknin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
Roberto Rodrigues Ferreira, Elen Mello de Souza, Gláucia Vilar-Pereira, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 13
Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-β-induced prostate stromal cells (WPMY-1) proliferation via PI3K/AKT signaling pathway
San Yoon Nwe, Tamonwan Uttarawichien, Teerawat Boonsom, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Inhibitory Effect of Thymoquinone on Testosterone‐Induced Benign Prostatic Hyperplasia in Wistar Rats
Bahaa Al‐Trad, Mazhar Salim Al Zoubi, Janti Qar, et al.
Phytotherapy Research (2017) Vol. 31, Iss. 12, pp. 1910-1915
Closed Access | Times Cited: 21
The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
Shuangshuang Wu, Dongyan Huang, Xin Su, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Tight junction protein claudin‐1 is downregulated by TGF‐β1 via MEK signaling in benign prostatic epithelial cells
Ke Wang, Laura E. Pascal, Feng Li, et al.
The Prostate (2020) Vol. 80, Iss. 14, pp. 1203-1215
Open Access | Times Cited: 16
Identification of a prolonged action molecular GLP-1R agonist for the treatment of femoral defects
Ning Wang, Xuanchen Liu, Lei Shi, et al.
Biomaterials Science (2020) Vol. 8, Iss. 6, pp. 1604-1614
Closed Access | Times Cited: 15
Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI
Bo Zhang, Xiang Chen, Chaoqun Xie, et al.
Experimental Cell Research (2019) Vol. 387, Iss. 1, pp. 111754-111754
Closed Access | Times Cited: 14
Association of anti‐inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice
Pedro Augusto Marischka Mateus, Larissa Akemi Kido, Rafael Sauce Silva, et al.
The Prostate (2018) Vol. 79, Iss. 5, pp. 515-535
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top